Literature DB >> 18266650

What is the "true" prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact?

Richard D Hayes1, Lorraine Dennerstein2, Catherine M Bennett3, Christopher K Fairley3.   

Abstract

INTRODUCTION: A wide range of prevalence estimates of female sexual dysfunctions (FSD) have been reported. AIM: Compare instruments used to assess FSD to determine if differences between instruments contribute to variation in reported prevalence. MAIN OUTCOME MEASURES: Sexual Function Questionnaire combined with Female Sexual Distress Scale (SFQ-FSDS) was our gold standard, validated instrument for assessing FSD. Alternatives were SFQ alone and two sets of simple questions adapted from Laumann et al. 1994. Methods. A postal survey was administered to a random sample of 356 Australian women aged 20 to 70 years.
RESULTS: When assessed by SFQ-FSDS, prevalence estimates (95% confidence intervals) of hypoactive sexual desire disorder, sexual arousal disorder (lubrication), orgasmic disorder, and dyspareunia were 16% (12% to 20%), 7% (5% to 11%), 8% (6% to 12%), and 1% (0.5% to 3%), respectively. Prevalence estimates varied across alternative instruments for these disorders: 32% to 58%, 16% to 32%, 16% to 33%, and 3% to 23%, respectively. Compared with SFQ-FSDS alternative instruments produced higher estimates of desire, arousal and orgasm disorders and displayed a range of sensitivities (0.25 to 1.0), specificities (0.48 to 0.99), positive predictive values (0.01 to 0.56), and negative predictive values (0.95 to 1.0) across the disorders investigated. Kappa statistics comparing SFQ-FSDS and alternative instruments ranged from 0 to 0.71 but were predominantly 0.44 or less. Changing recall from previous month to 1 month or more in the previous year produced higher estimates for all disorders investigated. Including sexual distress produced lower estimates for desire, arousal, and orgasm disorders.
CONCLUSIONS: Prevalence estimates of FSD varied substantially across instruments. Relatively low positive predictive values and kappa statistics combined with a broad range of sensitivities and specificities indicated that different instruments identified different subgroups. Consequently, the instruments researchers choose when assessing FSD may affect prevalence estimates and risk factors they report.

Entities:  

Mesh:

Year:  2008        PMID: 18266650     DOI: 10.1111/j.1743-6109.2007.00768.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  35 in total

1.  Childhood sexual abuse moderates the association between sexual functioning and sexual distress in women.

Authors:  Kyle R Stephenson; Corey P Hughan; Cindy M Meston
Journal:  Child Abuse Negl       Date:  2012-03-03

Review 2.  Sexual function in women: what is normal?

Authors:  Claudine Domoney
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05

3.  Significant resolution of female sexual dysfunction after bariatric surgery.

Authors:  Dale S Bond; Rena R Wing; Sivamainthan Vithiananthan; Harry C Sax; G Dean Roye; Beth A Ryder; Dieter Pohl; Jeannine Giovanni
Journal:  Surg Obes Relat Dis       Date:  2010-06-04       Impact factor: 4.734

4.  Translation and validation of the Greek version of the female sexual function index questionnaire.

Authors:  A Zachariou; M Filiponi; P S Kirana
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

Review 5.  The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.

Authors:  Sheryl A Kingsberg; Anita H Clayton; James G Pfaus
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

6.  Brain activation patterns in women with acquired hypoactive sexual desire disorder and women with normal sexual function: a cross-sectional pilot study.

Authors:  Terri L Woodard; Nicole T Nowak; Richard Balon; Manuel Tancer; Michael P Diamond
Journal:  Fertil Steril       Date:  2013-07-02       Impact factor: 7.329

7.  Long-term quality of life in Australian women previously diagnosed with gynaecologic cancer.

Authors:  Lesley Stafford; Fiona Judd
Journal:  Support Care Cancer       Date:  2010-12-31       Impact factor: 3.603

8.  Internal pudendal artery from type 2 diabetic female rats demonstrate elevated endothelin-1-mediated constriction.

Authors:  Kyan J Allahdadi; Johanna L Hannan; Adviye Ergul; Rita C Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2011-06-30       Impact factor: 3.802

9.  Why is impaired sexual function distressing to women? The primacy of pleasure in female sexual dysfunction.

Authors:  Kyle R Stephenson; Cindy M Meston
Journal:  J Sex Med       Date:  2014-12-29       Impact factor: 3.802

10.  Sexual dysfunctions in patients with diabetes: a study from Iran.

Authors:  Marzieh Ziaei-Rad; Mariam Vahdaninia; Ali Montazeri
Journal:  Reprod Biol Endocrinol       Date:  2010-05-18       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.